Literature DB >> 9494248

Our experience in the arthroscopic treatment of fracture-avulsion of the tibial spine.

L Osti1, F Merlo, L Bocchi.   

Abstract

The authors present their experience in the arthroscopic treatment of fracture-avulsion of the intercondyloid eminence in the adult with a variation in the original method. In fact, an ACUFEX tibial guide is used for reconstruction of the ACL positioning 2 Kirschner wires with hole at the margins of the fragment, successively sliding the metal wire through the hole. Successive traction on the outside of the wires allows the metal wires to be arranged dome-like to stabilize the avulsed fragment. The distal ends of the wires are stabilized with a metal pull-out in the area corresponding to the anteromedial surface of the tibia. In the 10 patients treated by this method, evaluated after a minimum follow-up of 6 months, we obtained overall satisfactory clinical and functional results. There was significant residual ligamentous laxity in 2 patients with no clinical symptoms of instability. Variations in arthroscopic technique described in the literature are analyzed.

Entities:  

Mesh:

Year:  1997        PMID: 9494248

Source DB:  PubMed          Journal:  Chir Organi Mov        ISSN: 0009-4749


  3 in total

1.  Tibial intercondylar eminence fractures in adults: arthroscopic treatment.

Authors:  A Delcogliano; S Chiossi; A Caporaso; A Menghi; G Rinonapoli
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2003-07-04       Impact factor: 4.342

2.  Physeal sparing arthroscopic fixation of displaced tibial eminence fractures: a new surgical technique.

Authors:  Michael T Hirschmann; Ralph R Mayer; Axel Kentsch; Niklaus F Friederich
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2009-02-19       Impact factor: 4.342

3.  Clinical outcome of arthroscopic reduction and suture for displaced acute and chronic tibial spine fractures.

Authors:  Jin Hwan Ahn; Jae Chul Yoo
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2004-11-20       Impact factor: 4.342

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.